Investigation of Nontuberculous Mycobacteria Outbreaks in Healthcare Settings
Official title: Transmission and Acquisition of Nontuberculous Mycobacteria Outbreak Investigation (TrANsMIt)
Run by University of North Carolina, Chapel Hill · NCT06155747 · Data updated 2026-11-12
This study is trying to find out if nontuberculous mycobacteria infections in healthcare settings are spreading between patients and where they might be coming from.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 1 Month to 99 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University of North Carolina, Chapel Hill Academic / other |
| Locations | 1 site (Chapel Hill, North Carolina) |
| Status | Recruiting |
| Started | March 1, 2023 |
| Main results expected | December 28, 2036 |
| Study ends | December 28, 2036 |
| Registry record updated | May 26, 2026 |
| Trial ID | NCT06155747 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals of any age with a history of nontuberculous mycobacteria or a first positive NTM culture from clinical care.
✕Probably not a fit
Patients who do not have a respiratory culture indicating nontuberculous mycobacteria will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to standardize the investigation of nontuberculous mycobacteria (NTM) outbreaks in healthcare facilities. It will analyze respiratory NTM isolates from patients to determine if they are genetically related, indicating potential patient-to-patient transmission. The study will also assess environmental samples to identify sources of NTM acquisition. Participants will complete a demographic questionnaire to support the epidemiological investigation. The research utilizes whole genome sequencing to identify clusters of infections and adapt CDC guidelines for outbreak investigations.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of NTM transmission in healthcare settings, leading to improved infection control measures.
How similar studies have gone: Other studies have successfully utilized whole genome sequencing for outbreak investigations, suggesting this approach may yield valuable insights.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female participant of any age who has a history of NTM or a first positive NTM culture collected as part of routine clinical care from expectorated sputum, induced sputum and/or bronchoalveolar lavage. Exclusion Criteria: * No NTM respiratory culture
Where it's running
-
University of North Carolina- Chapel Hill
Chapel Hill, North Carolina, United States Recruiting
Study contacts
- Principal investigator: Jane Gross, MD, PhD — University of North Carolina, Chapel Hill
- Study coordinator: Principal Investigator
- Email: Jane_gross@med.unc.edu
- Phone: 919-445-4240
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Early treatment with targeted antibiotics for severe infections using rapid diagnostics
This study is testing if giving targeted antibiotics right away, based on quick test results, can help hospitalized patients with severe infections caused by tough-to-treat bacteria feel better faster than standard care.
-
Gene expression profiles in spinal tuberculosis
This study is trying to see if different gene patterns in spinal tuberculosis can help doctors better understand and treat the disease, especially in people with HIV.
-
Understanding the natural history of tuberculosis
This study is trying to learn more about tuberculosis by collecting samples and monitoring treatment in people with active or latent TB to improve how we understand and treat the disease.
-
Examining Mycobacterial Infections
This study is trying to learn more about non-tuberculous mycobacterial infections in people with certain health conditions to see how they affect symptoms and treatment options.
-
BCG vaccine to treat MAC lung disease
This will test whether a single BCG vaccine injection can safely boost immunity and help adults with Mycobacterium avium complex (MAC) lung disease.
-
Rehabilitation and education for airway clearance in patients with NTM-PD
This study is testing if an 8-week program of lung exercises and education can help adults with nontuberculous mycobacterial pulmonary disease breathe better and feel healthier.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.